Fiche société
Damascus University
Traitements, essais et publications liés.
Traitements3programmes
Essais1liés
Publications6liées
SourceDBlocale
Traitements
3| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| IVIG (Intravenous Immunoglobulin)This study compares the clinical effectiveness of Intravenous Immunoglobulin (IVIG) versus Plasma Exchange (PLEX) in patients experiencing a myasthenic crisis. Clinical response is evaluated 14 days post-treatment using the Quantitative Myasthenia Gravis Score (QMG). Additionally, the study aims to identify and report common precipitating factors for myasthenic attacks, such as respiratory infections or surgical stress. | Myasthénie | Non applicable | À vérifier | Syria | À vérifier |
| Plasma exchange (PE)This study compares the clinical effectiveness of Intravenous Immunoglobulin (IVIG) versus Plasma Exchange (PLEX) in patients experiencing a myasthenic crisis. Clinical response is evaluated 14 days post-treatment using the Quantitative Myasthenia Gravis Score (QMG). Additionally, the study aims to identify and report common precipitating factors for myasthenic attacks, such as respiratory infections or surgical stress. | Myasthénie | Non applicable | À vérifier | Syria | À vérifier |
| IVIG (Intravenous Immunoglobulin)This study compares the clinical effectiveness of Intravenous Immunoglobulin (IVIG) versus Plasma Exchange (PLEX) in patients experiencing a myasthenic crisis. Clinical response is evaluated 14 days post-treatment using the Quantitative Myasthenia Gravis Score (QMG). Additionally, the study aims to identify and report common precipitating factors for myasthenic attacks, such as respiratory infections or surgical stress. | Myasthénie | Non applicable | À vérifier | Syria | À vérifier |
Essais cliniques
1| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| IVIG (Intravenous Immunoglobulin) | Myasthénie | Non applicable | NCT07532707 | Efficacy of IVIG Versus PLEX in Myasthenic Crisis in Syria. | COMPLETED |
Publications
6| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| IVIG (Intravenous Immunoglobulin) | MOGAD-Associated Recurrent Optic Neuritis Unresponsive to Corticosteroids: Clinical, Visual Field, and OCT Correlation. | Romanian journal of ophthalmology | ||
| IVIG (Intravenous Immunoglobulin) | Flat dose intravenous immunoglobulin primary infection prophylaxis in multiple myeloma patients on BCMA and GPRC5D bispecific antibody therapy: the Vanderbilt experience. | Frontiers in immunology | ||
| IVIG (Intravenous Immunoglobulin) | Bilateral Blindness Due to Radiation-Induced Optic Neuropathy in a Patient with Nasal Mucosal Melanoma. | Romanian journal of ophthalmology | ||
| Plasma exchange (PE) | Efficacy and safety of double plasma cytokine adsorption system with sequential low-volume plasma exchange in treating acute-on-chronic liver failure complicated by sepsis: protocol for a multicentre randomised controlled clinical trial. | BMJ open | ||
| Plasma exchange (PE) | Serum Profiles of Pembrolizumab, Cardiac Troponin T, and Interleukin-6 in a Plasma Exchange-Treated Patient With Immune Checkpoint Inhibitor-Related Myocarditis. | Therapeutic drug monitoring | ||
| Plasma exchange (PE) | An observational study on lupus nephritis combined with cryoglobulinemia. | Renal failure |